Sökning: onr:"swepub:oai:DiVA.org:uu-205549" > Identification of C...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06058naa a2200673 4500 | |
001 | oai:DiVA.org:uu-205549 | |
003 | SwePub | |
008 | 130819s2013 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:kth-139205 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2055492 URI |
024 | 7 | a https://doi.org/10.1371/journal.pone.00817122 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-1392052 URI |
040 | a (SwePub)uud (SwePub)kth | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Darmanis, Spyrosu Uppsala universitet,Molekylära verktyg,Science for Life Laboratory, SciLifeLab4 aut0 (Swepub:uu)spyda949 |
245 | 1 0 | a Identification of Candidate Serum Proteins for Classifying Well-Differentiated Small Intestinal Neuroendocrine Tumors |
264 | c 2013-11-25 | |
264 | 1 | b Public Library of Science (PLoS),c 2013 |
338 | a electronic2 rdacarrier | |
500 | a QC 20140113 | |
520 | a BackgroundPatients with well-differentiated small intestine neuroendocrine tumors (WD-SI-NET) are most often diagnosed at a metastatic stage of disease, which reduces possibilities for a curative treatment. Thus new approaches for earlier detection and improved monitoring of the disease are required.Materials and methodsSuspension bead arrays targeting 124 unique proteins with antibodies from the Human Protein Atlas were used to profile biotinylated serum samples. Discoveries from a cohort of 77 individuals were followed up in a cohort of 132 individuals both including healthy controls as well as patients with untreated primary WD-SI-NETs, lymph node metastases and liver metastases.Results A set of 20 antibodies suggested promising proteins for further verification based on technically verified statistical significance. Proceeding, we assessed the classification performance in an independent cohort of patient serum, achieving, classification accuracy of up to 85% with different subsets of antibodies in respective pairwise group comparisons. The protein profiles of nine targets, namely IGFBP2, IGF1, SHKBP1, ETS1, IL1α, STX2, MAML3, EGR3 and XIAP were verified as significant contributors to tumor classification.ConclusionsWe propose new potential protein biomarker candidates for classifying WD-SI-NET at different stage of disease. Further evaluation of these proteins in larger sample sets and with alternative approaches is needed in order to further improve our understanding of their functional relation to WD-SI-NET and their eventual use in diagnostics. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinsk bioteknologix Medicinsk bioteknologi0 (SwePub)304012 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Medical Biotechnologyx Medical Biotechnology0 (SwePub)304012 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Cell- och molekylärbiologi0 (SwePub)301082 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Cell and Molecular Biology0 (SwePub)301082 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Gastroenterologi0 (SwePub)302132 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Gastroenterology and Hepatology0 (SwePub)302132 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinsk bioteknologi0 (SwePub)3042 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Medical Biotechnology0 (SwePub)3042 hsv//eng |
653 | a Endokrinologi och Diabetologi | |
653 | a Endocrinology and Diabetology | |
653 | a Molecular Biology | |
653 | a Molekylärbiologi | |
653 | a Molekylär bioteknik | |
653 | a Molecular Biotechnology | |
653 | a Oncology | |
653 | a Onkologi | |
653 | a Growth-Factor | |
700 | 1 | a Cui, Taou Uppsala universitet,Onkologisk endokrinologi4 aut0 (Swepub:uu)taocu332 |
700 | 1 | a Drobin, Kimiu KTH,Proteomik och nanobioteknologi,Science for Life Laboratory, SciLifeLab,KTH - Royal Institute of Technology, Stockholm, Sweden,Science for Life Laboratory, School of Biotechnology4 aut0 (Swepub:kth)u130lrx0 |
700 | 1 | a Li, Su-Chenu Uppsala universitet,Onkologisk endokrinologi4 aut0 (Swepub:uu)suali171 |
700 | 1 | a Öberg, Kjellu Uppsala universitet,Onkologisk endokrinologi,Science for Life Laboratory, SciLifeLab4 aut0 (Swepub:uu)kjellob |
700 | 1 | a Nilsson, Peteru KTH,Proteomik och nanobioteknologi,Science for Life Laboratory, SciLifeLab,KTH - Royal Institute of Technology, Stockholm, Sweden,Science for Life Laboratory, School of Biotechnology4 aut0 (Swepub:kth)u1ws88sk |
700 | 1 | a Schwenk, Jochen M.u KTH,Proteomik och nanobioteknologi,Science for Life Laboratory, SciLifeLab,KTH - Royal Institute of Technology, Stockholm, Sweden,Science for Life Laboratory, School of Biotechnology4 aut0 (Swepub:kth)u1h7wtme |
700 | 1 | a Giandomenico, Valeriau Uppsala universitet,Onkologisk endokrinologi,Science for Life Laboratory, SciLifeLab4 aut0 (Swepub:uu)valegian |
710 | 2 | a Uppsala universitetb Molekylära verktyg4 org |
773 | 0 | t PLOS ONEd : Public Library of Science (PLoS)g 8:11, s. e81712-q 8:11<e81712-x 1932-6203 |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:644274/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0081712&type=printable |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-205549 |
856 | 4 8 | u https://doi.org/10.1371/journal.pone.0081712 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-139205 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy